EP3656765

GRNENTHAL
Application Number
EP19214275A
Filing Date
Jul 22, 2011
Status
Granted And Under Opposition
Mar 12, 2021
Grant Date
Apr 14, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3656765B1 was granted on Apr 14, 2021 by Grnenthal The patent is currently Granted And Under Opposition.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

HAMM&WITTKOPP PATENTANWALTE PARTMBBJan 14, 2022WITHDRAWN
PAJAROJan 14, 2022WITHDRAWN
MSN LABORATORIES PVTJan 13, 2022ADMISSIBLE
INSUD PHARMA SLJan 13, 2022WITHDRAWN
KRAUS & LEDERER PARTGMBBJan 13, 2022WITHDRAWN
G L PHARMAApr 15, 2021WITHDRAWN

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionEP3377049B1
N/A
OppositionEP0693475
N/A
OppositionWO2007128412
N/A
OppositionWO03035053
N/A
OppositionWO2006002886
N/A
OppositionWO2008012047
N/A
OppositionWO2012010316
N/A
OppositionWO2008128739
N/A
OppositionWO2012051246
N/A

Access Full Citation Information

Get a free, in-depth citation report including examiner, opposition, and international search citations.

Get Free Citation Report

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.